Advisor Resource Council Supernus Pharmaceuticals, Inc. Transaction History

Advisor Resource Council

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$28.51 - $32.9 $2.23 Million - $2.57 Million	-78,245 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$26.37 - $34.22 $712,965 - $925,206	27,037 Added 52.8%	78,245 $2.28 Million
Q3 2021 Nov 16, 2021	BUY	$23.54 - $31.39 $1.2 Million - $1.6 Million	51,094 Added 44819.3%	51,208 $1.37 Million
Q2 2021 Aug 13, 2021	BUY	$26.72 - $33.19 $3,046 - $3,783	114 New	114 $3,000

283

60.8M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.02B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

Stay updated on Advisor Resource Council with notifications on news.